Average Co-Inventor Count = 6.08
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (30 from 1,829 patents)
2. Dendreon Corporation (5 from 53 patents)
3. Other (1 from 832,880 patents)
31 patents:
1. RE43298 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
2. 8067379 - Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
3. 7595299 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
4. 7485645 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
5. 7432268 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
6. 7271175 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
7. 7244721 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
8. 7169760 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
9. 7138396 - 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
10. 7053091 - 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
11. 7012066 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
12. 6903102 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
13. 6894072 - Compounds as NS3-serine protease inhibitors of hepatitis C virus
14. 6800434 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
15. 6440974 - Compounds useful for inhibition of farnesyl protein transferase